Summary & Overview
HCPCS A4630: Replacement Batteries for Transcutaneous Electrical Stimulator
HCPCS Level II code A4630 denotes replacement batteries that are medically necessary for transcutaneous electrical stimulators owned by the patient. Nationally, this code supports coverage and billing for an essential consumable component of transcutaneous electrical stimulation therapy used for pain management and neuromodulation. Accurate use of A4630 affects reimbursement for suppliers and continuity of patient home therapy.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of payer coverage considerations, common modifiers used with supply and DME billing, and clinical context for when replacement batteries are billed separately from the device. The publication also outlines typical sites of service and the role of A4630 in supply chains for home-based electrical stimulation.
This summary highlights benchmarks for utilization and reimbursement policy trends, payer-specific prior authorization and documentation expectations where available, and practical coding notes affecting billing workflows. Data not available in the input is noted where applicable; the report focuses on national policy and billing implications rather than state-specific rules.
Billing Code Overview
HCPCS Level II code A4630 identifies replacement batteries that are medically necessary for transcutaneous electrical stimulators and are owned by the patient. This supply-level code covers batteries provided to patients to power transcutaneous electrical nerve stimulation (TENS) or other transcutaneous electrical stimulation devices when replacement is required for ongoing therapy.
Service Type: Durable medical equipment supply / replacement part
Typical Site of Service: Outpatient settings, home use, durable medical equipment suppliers, and retail medical supply locations
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with chronic neuropathic pain uses a patient-owned transcutaneous electrical nerve stimulator (TENS) daily. The device requires periodic replacement batteries to maintain effective therapy. The patient presents to a durable medical equipment (DME) supplier or outpatient clinic requesting replacement batteries for the owned TENS unit. The clinician documents medical necessity based on persistent pain despite conservative measures, ongoing use of the TENS device, and prior authorization or DME coverage criteria when required. The supplier verifies device ownership, matches battery specification to the patient’s stimulator model, dispenses replacement batteries coded as A4630, and submits claims with appropriate modifiers for payer adjudication. Typical site of service is an outpatient DME provider location, retail medical supply store, or outpatient clinic where DME is dispensed and billed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default / No modifier | Use when no specific modifier applies. |
22 | Increased procedural services |